ArticleBritish journal of cancer2018

Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma.

Nada M S Al-Saffar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.